66
Views
9
CrossRef citations to date
0
Altmetric
Original Research

Warfarin slows deterioration of renal function in elderly patients with chronic kidney disease and atrial fibrillation

, , , , , & show all
Pages 523-529 | Published online: 10 May 2013

References

  • FeestTGRajamaheshJByrneCTrends in adult renal replacement therapy in the UK: 1982–2002QJM2005981212815625350
  • LisowskaATycińskaAKnappMThe incidence and prognostic significance of cardiac arrhythmias and conduction abnormalities in patients with acute coronary syndromes and renal dysfunctionKardiol Pol20116912:12421247 Polish22219098
  • RileyABManningWJAtrial fibrillation: an epidemic in the elderlyExpert Rev Cardiovasc Ther2011981081109021878052
  • NabauerMGerthALimbourgTThe Registry of the German Competence NETwork on Atrial Fibrillation: patient characteristics and initial managementEuropace200911442343419153087
  • FurbergCDPsatyBMManolioTAPrevalence of atrial fibrillation in elderly subjects (the Cardiovascular Health Study)Am J Cardiol19947432362418037127
  • HorioTIwashimaYKamideKChronic kidney disease as an independent risk factor for new-onset atrial fibrillation in hypertensive patientsJ Hypertens20102881738174420485194
  • GoASHylekEMPhillipsKAPrevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) StudyJAMA2001285182370237511343485
  • WolfPAAbbottRDKannelWBAtrial fibrillation as an independent risk factor for stroke: the Framingham studyStroke19912289839881866765
  • PicciniJPWallaceTWPatelMRBeckerRCStroke prevention in atrial fibrillationCardiovasc Drugs Ther201125656157021927837
  • GageBFWatermanADShannonWValidation of clinical classification schemes for predicting stroke. Results from the national registry of atrial fibrillationJAMA2001285222864287011401607
  • NakagawaKHiraiTTakashimaSChronic kidney disease and CHADS2 score independently predict cardiovascular events and mortality in patients with nonvalvular atrial fibrillationAm J Cardiol2011107691291621247518
  • SandhuRKKurthTConenDRelation of renal function to risk for incident atrial fibrillation in WomenAm J Cardiol2012109453854222100025
  • HartRGPearceLAAsingerRWWarfarin in atrial fibrillation patients with moderate chronic kidney diseaseClin J Am Soc Nephrol20116112599260421903982
  • [No authors listed] Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trialsArch Intern Med199415413144914578018000
  • TulnerLRVan CampenJPKuperIMReasons for under treatment with oral anticoagulants in frail geriatric outpatients with atrial fibrillation: a prospective, descriptive studyDrugs Aging2010271395020030431
  • BrodskySVNadasdyTRovinBHWarfarin-related nephropathy occurs in patients with and without chronic kidney disease and is associated with an increased mortality rateKidney Int201180218118921389969
  • LeveyASCoreshJBalkENational Kidney FoundationNational Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratificationAnn Intern Med2003139213714712859163
  • von ElmEAltmanDGEggerMPocockSJGøtzschePCVandenbrouckeJPSTROBE InitiativeThe Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studiesPLoS Med2007410e29617941714
  • CammAJKirchhofPLipGYEuropean Heart Rhythm Association, European Association for Cardio-Thoracic Surgery, Guidelines for the management of atrial fibrillationEur Heart J201031192369242920802247
  • EzekowitzMDLevineJAPreventing stroke in patients with atrial fibrillationJAMA1999281191830183510340371
  • KameiKNakanishiKItoSLong-term results of a randomized controlled trial in childhood IgA nephropathyClin J Am Soc Nephrol2011661301130721493743
  • YanagitaMThe role of the vitamin K-dependent growth factor Gas6 in glomerular pathophysiologyCurr Opin Nephrol Hypertens200413446547015199298
  • NagaiKMatsubaraTMimaAGas6 induces Akt/mTOR-mediated mesangial hypertrophy in diabetic nephropathyKidney Int200568255256116014032
  • YanagitaMIshiiKOzakiHMechanism of inhibitory effect of warfarin on mesangial cell proliferationJ Am Soc Nephrol199910122503250910589688
  • MatésJMPérez-GómezCNúñez de CastroIGlutamine and its relationship with intracellular redox status, oxidative stress and cell proliferation/deathInt J Biochem Cell Biol200234543945811906817
  • OzcanAWareKCalomeniE5/6 Nephrectomy as a validated rat model mimicking human warfarin-related nephropathyAm J Nephrol201235435636422473220
  • ZebboudjAFShinVBostromKMatrix GLA protein and BMP-2 regulate osteoinduction in calcifying vascular cellsJ Cell Biochem200390475676514587031
  • ProudfootDSkepperJNHegyiLApoptosis regulates human vascular calcification in vitro: evidence for initiation of vascular calcification by apoptotic bodiesCirc Res200087111055106211090552
  • BrodskySVSatoskarAChenJAcute kidney injury during warfarin therapy associated with obstructive tubular red blood cell casts: a report of 9 casesAm J Kidney Dis20095461121112619577348
  • MantJHobbsFDFletcherKWarfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomized controlled trialLancet2007370958649350317693178
  • AliABaileyCAbdelhafizAHStroke prevention with oral anticoagulation in older people with atrial fibrillation – a pragmatic approachAging Dis20123433935123185715